Promoted to News Center home page.
New material and mass production process from Stanford engineer could enable foldable touchscreens, electronic clothing and, one day, synthetic skin.
Rachael Flatt competed in the 2010 Winter Olympics. Now the former skater works on eating disorders prevention and intervention in a Stanford Medicine lab.
In this essay, medical student Natasha Abadilla reflects on the walls that medical trainees put up between themselves and their patients.
Stanford's Russ Altman discussed the pharmgkb.org database — which matches genomes with medication information — at the recent Beckman Symposium on campus.
This Stanford Medicine study clarifies the underlying biology of high-grade serous ovarian cancer and could help lead to future therapies.
Stanford pain expert Beth Darnall discusses her clinical trials on methods to taper opioid doses for patients with chronic pain.
A comparison of diets for weight loss for those with different levels of insulin and metabolic genes did not find a clear winner.
A team of former Stanford Biodesign students developed a device to protect and stabilize umbilical cord catheters in newborn babies.
Even adults who are not considered "high-risk" should be tested to reduce deaths and improve cure rates, new Stanford Health Policy research suggests.
Researchers have assumed that "synonymous" mutations don't matter. Now it looks like they're among the most important for creating species diversity.
Abdominal aortic aneurysms may be caused by the overexpression of a "don't eat me" protein that blocks the disposal of dead and dying cells.
Douglas Lowy, deputy director of the National Cancer Institute, recently spoke at Stanford Medicine.
Several severely depressed patients were helped by a new, experimental form of transcranial magnetic stimulation developed by Stanford Medicine researchers.
During a stop at Stanford, Renee Fleming shared her thoughts on the intersection of music and medicine.
Theirs was a rare partnership, a poignant love story of recovery and renewal. The "dream team" lasted 25 years. And then it was time to say goodbye.
A look at the lab and work of Brian Kobilka, who won the 2012 Nobel Prize in Chemistry.
